Bio 2000 Breaks Records: Most Successful Biotech Conference Ever!Business/Technology Editors and Health/Medical Writers BIO bi·o n. pl. bi·os Informal 1. A biography. 2. A biographical sketch or outline. 2000 BOSTON--(BW HealthWire)--March 30, 2000 Bio 2000 broke all previous records for attendance and involvement by scientists, academic researchers, company executives, patient advocates, government officials and investment experts. "By far, this was the best attended and most successful international meeting and exhibition the biotechnology biotechnology, the use of biological processes, as through the exploitation and manipulation of living organisms or biological systems, in the development or manufacture of a product or in the technological solution to a problem. industry has ever held," said Carl Feldbaum, President of the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
Boston, town (1991 pop. 26,495), E central England, on the Witham River. Boston's fame as a port dates from the 13th cent., when it was a Hanseatic port trading wool and wine. Having recovered from a decline in the 18th and 19th cent. for all of their help and cooperation in making Bio 2000 such an overwhelming success." Feldbaum said that Boston lived up to its reputation as a venue venue In law, the place or county in which the events giving rise to a legal action take place and from which a jury may be drawn to try the case. Venue statutes usually specify that a trial must take place in the district that has jurisdiction over the matter. for informed dialogue and spirited debate. "Boston has a long tradition of spirited public discourse For other uses, see Discourses. Discourse is communication that goes back and forth (from the Latin, discursus, "running to and fro"), such as debate or argument. The term is used in semantics and discourse analysis. about the issues of the day. As our industry continues its phenomenal growth, we are recommitting ourselves to a new level of public education about the benefits and challenges facing this industry." Feldbaum said. Conference Facts:
- Almost doubling registration from 5,700 in 1999 to over 10,280
this year.
- A rise in international participants from 1,650 in 1999 to over
2,000 this year.
- An increase in the number of exhibit booths from 450 in 1999 to
770 in 2000.
- More than doubling the number of middle school, secondary and
community college teachers in an industry sponsored teacher
professional development program. 110 teachers, a third of whom
were from outside New England, participated in the event at
industry expense compared to 50 participants last year.
- The largest ever Technology Transfer Forum where 124 scientists
from more than 25 academic institutions worldwide presented their
research.
- A free on-site job fair where a record 65 companies interviewed
almost 2,500 prospective employees.
- The industry's largest international partnering forum ever where
over 950 meetings were arranged for representatives from 33 major
companies to discuss potential collaboration.
- The BIOGENEius competition recognizing the top biotech high
school science projects from the New England region. The
Massachusetts Biotechnology Council awarded 23 local students
scholarships of $2,500 based on academic and extracurricular
performance and leadership. In total, more than $75,000 in
scholarships were awarded to high school students interested in
biotechnology, the highest amount ever.
- Creation of the Robert Swanson Memorial Scholarship in memory of
the co-founder of Genentech.
- A highly successful global roundtable which addressed issues and
challenges confronting both industrialized and developing
countries involved in commercial biotechnology efforts for
meeting needs in human health, agriculture, environment and
industrial processes.
- Visits by 10 individuals suffering from debilitating diseases or
injuries like Christopher Reeve, who told their personal stories
and are either benefiting currently from biotech drugs or are
looking to this industry for new treatments to improve the
quality of their lives.
- 2381/2hours of symposia and seminars.
|
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion